Looking for fresh investing inspiration? We have the perfect tool for you. TipRanks has now revamped its powerful stock screener to enable users to take advantage of our unique and valuable stock insights. 

The upgraded screener includes many exciting new datasets enabling you to refine your search options and find high-quality investing inspiration more easily and efficiently than ever before. New filters include Analyst Price Target and Best Analyst Price Target. The Analyst Price Target specifically is an extremely useful filter that lets you find stocks the Street thinks are set to soar. Using this filter, you can limit the results to only ‘Strong Buy’ stocks with over 10 or 20% upside potential from the current share price to the average analyst price target.

Here we used the following filters: Market Cap Over $300M; All Sectors; Strong Buy Consensus, Upside of Over 10%, Bullish News Sentiment, Bullish Blogger Sentiment 

From the generated results, these 10 stocks stood out. Bear in mind the analyst consensus is based on ratings from the last three months. Let’s take a closer look now:

1. Alphabet (Nasdaq:GOOGL)

• Strong Buy (29 buy ratings, 3 hold ratings), $1,378 average analyst price target (10% upside potential)

Five-star Monness analyst Brian White has just returned from the Google Cloud conference. This was a ‘Big Day for AI’ says White, as the “new innovations unveiled and capabilities added… will continue to drive momentum in the Google Cloud.” He has a $1,415 price target on the stock (13% upside potential).  

2. Edwards Lifesciences (NYSE:EW)

• Strong Buy (6 buy ratings, 1 hold rating), $156 average analyst price target (10% upside potential)

“Buy EW aggressively here” states top Canaccord Genuity analyst Jason Mills. He has a $177 price target on this medical device stock (25% upside potential). “The reason we are adamant about adding to positions owes to our belief that the firm will deliver accelerating growth in Transcatheter Valve Therapy (TVT) revenue over the next 2 quarters, and quite possibly the next 4 to 6, given myriad catalysts (new products, CAP trial, low risk data and indication expansion through H2:19).”  View EW Price Target & Analyst Rating Details

3. Micron (NASDAQ:MU)

• Strong Buy (17 buy ratings, 3 hold ratings), $85 average analyst price target (57% upside potential)

Following another stellar beat/raise quarter, top Needham analyst Rajvindra Gill reiterated his ‘Strong Buy’ rating on MU. For Gill, this red-hot chip stock “is benefiting from systematic, structural changes occurring in the memory industry where memory is becoming a strategic differentiator in high performance computing.” Gill’s $100 price target indicates massive upside potential of over 85%.  View MU Price Target & Analyst Rating Details

4. Wix.com Ltd (Nasdaq:WIX)

• Strong Buy (9 buy ratings, 2 hold ratings), $112 average analyst price target (11% upside potential)

Wix is a rapidly expanding cloud-based web-development platform. The stock is attracting strong attention from the Street. Most recently, Oppenheimer’s Jason Helfstein ramped up his price target from $105 to $125 (23% upside potential). He says the stock is undervalued compared to peers, especially when you factor in an impressive Q2.  View WIX Price Target & Analyst Rating Details

5. Mastercard (NYSE:MA)

• Strong Buy (18 buy ratings, 1 hold rating), $229 average analyst price target (13% upside potential)

“We like Mastercard’s ability to grow faster than peers and its potential to expand margins” cheers top Cantor Fitzgerald analyst Joseph Foresi. He adds: “Results for 2Q18 were above street expectations, with solid growth across all segments.” As a result, Foresi boosted his price target from $213 to $237 (17% upside potential).  View MA Price Target & Analyst Rating Details

6. Monolithic Power (Nasdaq:MPWR)

• Strong Buy (9 buy ratings), $157 average analyst price target (18% upside potential)

Monolithic Power is a leading power solutions company with 100% top analyst support. “Shares are up ~450% over the past five years (~2x SOX). Management continues to build on its long history of consistent execution. We remain long-term buyers of this early innings growth/GM story” enthuses Oppenheimer’s Rick Schafer. Plus “the balance sheet is pristine, with zero-debt and $7+/share cash.”  View MPWR Price Target & Analyst Rating Details

7. Reata Pharmaceuticals (Nasdaq:RETA)

• Strong Buy (4 buy ratings), $114 average analyst price target (53% upside potential)

Citi analyst Yigal Nochomovitz has just elevated Reata to ‘Top Pick’ status and added the stock to the firm’s US Focus List. He made the move following the company’s “exceptional data” for Alport syndrome. This is a genetic disorder affecting around 1 in 50,000 children. This top analyst now has “solid confidence” for bardoxolone methyl in other rare kidney diseases. Also note that his $185 price target suggests massive upside potential of almost 150%.  View RETA Price Target & Analyst Rating Details

8. Exact Sciences (Nasdaq:EXAS)

• Strong Buy (6 buy ratings), $75 average analyst price target (28% upside potential)

Exact Sciences Corp. is a molecular diagnostics company focusing on the early detection and prevention of cancer. “Given early days still (~2-3% penetrated), EXAS remains a top pick and is well positioned for robust growth” applauds Canaccord Genuity’s Mark Massaro. He is excited about the possibility of EXAS expanding to liver cancer tests- a $1.5 billion opportunity that could launch as early as 2019. Massaro’s $75 price target suggests 27% upside potential. View EXAS Price Target & Analyst Rating Details

9. Marathon Petroleum (NYSE:MPC)

• Strong Buy (5 buy ratings, 1 hold rating), $98 average analyst price target (21% upside potential)

Ohio-based Marathon Petroleum is the US’s second-largest refiner. It has a crude oil refining capacity of approximately 1.9 million barrels per day. MPC is in the process of acquiring ANDV, and achieving a $1 billion synergy target would be a major catalyst for shares says top RBC Capital analyst Brad Heffern.  View MPC Price Target & Analyst Rating Details

10. Amazon (Nasdaq:AMZN)

• Strong Buy (38 buy ratings, 1 hold rating), $2,081 average price target (15% upside potential)

“Excellent Execution” exclaimed top Monness analyst Brian White on AMZN’s earnings. “Last night, Amazon delivered big 2Q:18 EPS upside and provided a strong 3Q:18 operating profit outlook. We are raising our profit estimates and increasing our 12-month price target to $2,300 from $2,200” wrote White on July 27. His Street-high price target translates to 27% upside potential.  View AMZN Price Target & Analyst Rating Details